GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis

被引:15
作者
Wang, Ding [1 ,2 ]
Wei, Xiaodong [1 ,2 ]
Chen, Xuyang [1 ,2 ]
Wang, Qian [1 ,2 ]
Zhang, Jinghua [1 ,2 ]
Kalvakolanu, Dhan V. [3 ]
Guo, Baofeng [4 ]
Zhang, Ling [1 ,2 ]
机构
[1] Jilin Univ, Key Lab Pathobiol, Minist Educ, Changchun, Peoples R China
[2] Jilin Univ, Dept Pathophysiol, Coll Basic Med Sci, Changchun, Peoples R China
[3] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Greenebaum NCI Comprehens Canc Ctr, Baltimore, MD 21201 USA
[4] Jilin Univ, Dept Plast Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
GRIM-19; CRC; p53; MDM2; SIRT7; EXPRESSION; OVEREXPRESSION; METASTASIS; MECHANISMS; ROS;
D O I
10.1016/j.yexcr.2021.112799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is the leading deadly cancer worldwide. Gene associated with retinoid-IFN-induced mortality-19 (GRIM-19), a novel tumor suppressor, has been reported to be expressed at low levels in human CRC. However, the role of GRIM-19 in CRC progression and the corresponding detailed mechanisms are unclear. The results of this study indicated that GRIM-19 expression is related to CRC progression. Overexpression of GRIM-19 was found to inhibit CRC cell proliferation and induce apoptosis in vitro and in vivo. Our results demonstrated that GRIM-19 suppresses CRC through posttranslational regulation of p53, in which SIRT7 is activated by GRIM-19 and triggers PCAF-mediated MDM2 ubiquitination, eventually stabilizing the p53 protein. We also observed that GRIM-19 enhances the effect of oxaliplatin against CRC. In conclusion, GRIM-19 plays an important role in CRC development and is a potential biomarker and therapeutic target for clinical treatment of CRC.
引用
收藏
页数:11
相关论文
共 32 条
[1]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[2]   GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells [J].
Barnich, N ;
Hisamatsu, T ;
Aguirre, JE ;
Xavier, R ;
Reinecker, HC ;
Podolsky, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :19021-19026
[3]   GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation [J].
Bu, Xianmin ;
Zhao, Chenghai ;
Wang, Wei ;
Zhang, Ning .
GENE, 2013, 512 (02) :198-205
[4]   miR-6743-5p, as a direct upstream regulator of GRIM-19, enhances proliferation and suppresses apoptosis in glioma cells [J].
Cao, Fang ;
Zhang, Qiang ;
Chen, Wei ;
Zheng, Feng ;
Ran, Qishan ;
He, Yang ;
Gao, Yang ;
Yao, Shengtao .
BIOSCIENCE REPORTS, 2017, 37
[5]  
Chen HJ, 2015, J BUON, V20, P438
[6]   Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization [J].
Chen, Wanhong ;
Liu, Qingbai ;
Fu, Bin ;
Liu, Kai ;
Jiang, Wenchao .
LIFE SCIENCES, 2018, 208 :232-238
[7]   The mitochondrial respiratory signaling and NFAT activity chain controls intracellular calcium essential for heart formation in Xenopus laevis [J].
Chen, Yong ;
Yuen, Wai Hong ;
Fu, Jianlin ;
Huang, Guochang ;
Melendez, Alirio J. ;
Ibrahim, Farazeela Bte Mohod ;
Lu, Hao ;
Cao, Xinmin .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (18) :6420-6432
[8]   Colorectal cancer [J].
Dekker, Evelien ;
Tanis, Pieter J. ;
Vleugels, Jasper L. A. ;
Kasi, Pashtoon M. ;
Wallace, Michael B. .
LANCET, 2019, 394 (10207) :1467-1480
[9]   Targeting p53 for the treatment of cancer [J].
Duffy, Michael J. ;
Synnott, Naoise C. ;
O'Grady, Shane ;
Crown, John .
SEMINARS IN CANCER BIOLOGY, 2022, 79 :58-67
[10]   GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:Ubiquinone oxidoreductase (complex I) [J].
Fearnley, IM ;
Carroll, J ;
Shannon, RJ ;
Runswick, MJ ;
Walker, JE ;
Hirst, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :38345-38348